Ozempic

Google fires protestors, NPR chaos, Humane's AI Pin, Startup tax crisis, sports betting scandal

All-In Podcast

A medication for weight loss, mentioned in a personal anecdote about going off it to eat more animals.

Dr. Ben Bikman: How To Reverse Insulin Resistance Through Diet, Exercise, & Sleep

FoundMyFitness

A GLP-1 agonist drug used for weight loss and type 2 diabetes management.

How Sugar & Processed Foods Impact Your Health | Dr. Robert Lustig

Andrew Huberman

A GLP-1 agonist (semaglutide) from Novo Nordisk, approved for diabetes and used off-label for weight loss.

Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects

Andrew Huberman

A GLP-1 agonist drug.

Jason Calacanis on Brooklyn Grit, Big Asks, The Magic of Thinking Big, and More

Tim Ferriss

A drug that Kevin Rose and Jason Calacanis discussed that spurred Jason to use it for weight loss, along with fasting and weightlifting.

E150: Israel/Gaza escalating or not? EU censorship regime, Penn donors revolt, GLP-1 hype cycle

All-In Podcast

A brand-name GLP-1 drug, discussed in relation to its role in the current hype cycle and effectiveness for weight loss.

Q&A on Zone 2 Exercise with Peter Attia, M.D.

Peter Attia MD

A GLP-1 agonist mentioned for its effectiveness in insulin sensitivity and weight loss, though it can cause initial low energy.

E139: Recapping Chamath's wedding, VC surplus, unions vs Hollywood, room-temp superconductors & more

All-In Podcast

Mentioned as an effective tool for weight loss.

The Sugar Doctor: The Simple Diet That Prevents 80% of Disease!

The Diary Of A CEO

The Microbiome Doctor: Doctors Were Wrong! The 3 Foods You Should Eat For Perfect Gut Health!

The Diary Of A CEO

The Stablecoin Future, Milei's Memecoin, DOGE for the DoD, Grok 3, Why Stripe Stays Private

All-In Podcast

A medication for type 2 diabetes and weight loss, used as an example of a successful product that could spin out from Arc Institute's research.

The All-In Holiday Spectacular

All-In Podcast

Mentioned as part of the 'miracle drugs' class that stormed biotech, with GLP-1s changing the face of everything.

DOGE unveils a roadmap, Unlocking GDP Growth, WW3 escalation, Fat cell memory

All-In Podcast

Mentioned as a GLP-1 agonist drug that aids in weight loss but is associated with weight regain upon cessation.

Peptide & Hormone Therapies for Health, Performance & Longevity | Dr. Craig Koniver

Andrew Huberman

A brand name for semaglutide, a GLP-1 agonist, which initially received FDA approval for type 2 diabetes and later for weight loss.

Tools for Nutrition & Fitness | Dr. Layne Norton

Andrew Huberman

A GLP-1 agonist, mentioned as a powerful appetite suppressant that helps with weight loss by controlling food intake rather than significantly increasing metabolism. Associated with side effects like nausea and slowed motility.

The Random Show — Blockchain/Crypto Investing, NFT Experiments, Dogecoin, Zen Buddhism, and More

Tim Ferriss

A subcutaneous injection that lowers blood glucose levels and has been shown to be cardioprotective. It also has a common side effect of weight loss but can cause nausea.

Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek]

Peter Attia MD

Branded name for semaglutide, used for type 2 diabetes treatment.

How to Rewire Your Brain & Learn Faster | Dr. Michael Kilgard

Andrew Huberman

Dave Ricks, CEO of Eli Lilly | The All-In Interview

All-In Podcast

Novo Nordisk's weekly GLP-1 drug, semaglutide, widely known for its effectiveness in weight loss and diabetes treatment.

How to Exercise & Eat for Optimal Health & Longevity | Dr. Gabrielle Lyon

Andrew Huberman

A GLP-1 agonist medication for weight loss, which can cause significant weight loss but requires proper nutrition and resistance training to mitigate skeletal muscle loss.

Transform Your Health by Improving Metabolism, Hormone & Blood Sugar Regulation | Dr. Casey Means

Andrew Huberman

A GLP-1 receptor agonist medication, discussed for its role in weight loss and its high cost, as well as concerns about long-term use and muscle loss.

In conversation with Reid Hoffman & Robert F. Kennedy Jr.

All-In Podcast

GLP-1 drug for diabetes and weight loss, discussed in the context of its high cost and the pharmaceutical industry's profit motive.

Break up Google, Starbucks CEO out, Kamala’s price controls, Boeing disaster, Kursk offensive

All-In Podcast

Type of GLP-1 (glucagon-like peptide-1) drug mentioned as a factor influencing consumer behavior, specifically reducing desire for sugary drinks and potentially impacting companies like Starbucks.

Bee AI: The Wearable Ambient Agent

Latent Space

Not explicitly mentioned, but related to health and wellness trends.